Specific Protein 1(SP1) Regulates the Epithelial-Mesenchymal Transition via Lysyl Oxidase-Like 2(LOXL2) in Pancreatic Ductal Adenocarcinoma

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-42501-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

McF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-Like 2 (LOXL2) Exhibit an Epithelial-To-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasivein Vitro

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Lysyl Oxidase-Like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer

Cancer Research
Cancer ResearchOncology
2017English

Snail-Overexpression Induces Epithelial-Mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-Tumorigenic Ductal Cells

Journal of Clinical Medicine
2019English

IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Cancer Research
Cancer ResearchOncology
2016English

Lysyl Oxidase Family Activity Promotes Resistance of Pancreatic Ductal Adenocarcinoma to Chemotherapy by Limiting the Intratumoral Anticancer Drug Distribution

Oncotarget
Oncology
2016English

miR-200a Regulates Epithelial-Mesenchymal to Stem-Like Transition via ZEB2 and Β-Catenin Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Role of LOXL2 in the Epithelial-Mesenchymal Transition and Colorectal Cancer Metastasis

Oncotarget
Oncology
2017English

miR-367 Promotes Epithelial-To-Mesenchymal Transition and Invasion of Pancreatic Ductal Adenocarcinoma Cells by Targeting the Smad7-TGF-Β Signalling Pathway

British Journal of Cancer
Cancer ResearchOncology
2015English

High PKD2 Predicts Poor Prognosis in Lung Adenocarcinoma via Promoting Epithelial–mesenchymal Transition

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy